medline.ch Urologie-Nephrologie

	Cytoreductive nephrectomy improves survival in metastatic papillary renal cell carcinoma: a population-based study with machine learning validation and landmark analysis. World J Urol Yuan R, Wang Z, Wu F, Li Z, He Y, Guo Q, Huang W, Xu S. PMID: 42236580 [PubMed - in process]
	Survival Outcomes of a Smoking Cessation Treatment Program After Diagnosis of Bladder Cancer. Eur Urol Oncol MacDonald LP, Kypriotakis G, Karam-Hage M, Minnix JA, Beneventi D, Cui Y, Blalock JA, Robinson JD, Alhalabi O, Hassanazadeh CJ, Lee BH, Navai N, Kamat AM, Dinney CP, Cinciripini PM, Bree KK. PMID: 42236415 [PubMed - as supplied by publisher]
	Re: Khan S, Papa N, Kneebone A, et al. Prospective Comparison of (64)Copper [(64)Cu]SAR-bisPSMA vs (68)Gallium[(68)Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.001. Eur Urol Ding G, Wang J, Wu J. PMID: 42236390 [PubMed - as supplied by publisher]
	Empagliflozin Versus Dapagliflozin and Urogenital Adverse Events in Type 2 Diabetes: A Target Trial Emulation. Diabetes Obes Metab Ljungberg C, Bonnesen K, Schmidt M, Vandenbroucke-Grauls C, Dalager-Pedersen M, Sørensen HT, Nørgaard M, Thomsen RW. PMID: 42236297 [PubMed - as supplied by publisher]
	Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Population-Based Study. Diabetes Obes Metab Alterman N, Toledano Y, Fallach N, Gross V, Zacay G. PMID: 42236270 [PubMed - as supplied by publisher]
	Using Donabedian's model to explore healthcare providers' perspectives on early recognition and initial management of paediatric acute kidney injury in rural Tanzania: a qualitative case study protocol. BMJ Open Peter DE, Mkoka DA, Temba P, Millanzi WC. PMID: 42236087 [PubMed - in process]
	Overview of Feminizing Genital Gender-Affirming Surgery. Obstet Gynecol Clin North Am McCracken M, Mishra K. PMID: 42236066 [PubMed - in process]
	Prostate Anatomy: What Is Relevant for a Nuclear Medicine Practitioner. J Nucl Med Technol Kim JH, Mao M, Doroudinia A, Colletti PM. PMID: 42236001 [PubMed - in process]
	Integration of PSMA PET into the New Recommendations from Prostate Cancer Working Group 4 for Prostate Cancer Trials. J Nucl Med Technol Kuo PH, Morris MJ. PMID: 42235999 [PubMed - in process]
	Prostate cancer: All black men aged 45-74 will be offered screening in major trial expansion. BMJ Iacobucci G. PMID: 42235994 [PubMed - in process]
	Impact of Renal Artery Diameter and Bridging Stent Length on Renal Outcomes of Patients Treated by Multi-Branch Endovascular Aortic Repair. J Vasc Surg Nunes VA, Theis C, Gomes VC, Obren-Brunson HV, Ferreira ZC, Huang Y, Pascarella L, Benrashid E, Maximus S, Parodi FE, Oderich GS, Farber MA. PMID: 42235838 [PubMed - as supplied by publisher]
	Electrochemical biosensor-based strategies for sensitive detection of prostate cancer biomarkers. Clin Chim Acta Saha A, Sharma K. PMID: 42235733 [PubMed - as supplied by publisher]
	Inflammatory biomarkers in chronic kidney disease. Clin Chim Acta Oriquat G, Mohammed MH, Badraldin SQ, Rizaev J, Abdusamiyeva N, Salih RM, Jaber MA. PMID: 42235730 [PubMed - as supplied by publisher]
	Novel biomarkers of diabetic kidney disease in type 1 diabetes. Clin Chim Acta Przezak A, Bielka W, Mol, Plewa P, Pawlik A. PMID: 42235729 [PubMed - as supplied by publisher]
	Diagnostic Delay Duration and Determinants in Hereditary Leiomyomatosis and Renal Cell Cancer: An Observational Study. J Am Acad Dermatol Udupa M, Bendayan E, Allen-Flanagan T, Gunyon M, Alamari A, Ouchene L, Marino TC, Kaouache M, Rahme E, Foulkes WD, Netchiporouk E. PMID: 42235607 [PubMed - as supplied by publisher]
	Chronic kidney disease, complex conditions, and advancing therapeutics: new hope and challenges. Lancet Lees JS, , Zhang L, Wyatt C, Fabian J, Wang AY, Oni L, Levin A. PMID: 42235560 [PubMed - as supplied by publisher]
	Advances in understanding the impact of sex on kidney health and disease. Lancet Lees JS, Stevens KI, Kotwal SS, Bruchfeld A, Levin A. PMID: 42235559 [PubMed - as supplied by publisher]
	Advances in the diagnosis and detection of chronic kidney disease. Lancet Lees JS, Zhang L, Anandh U, Kronbichler A, Fisher LA, Borg M, Wang AY, Levin A. PMID: 42235558 [PubMed - as supplied by publisher]
	Explainable artificial intelligence in prostate cancer treatment recommendation: A decision support system for oncological expert panels. Eur J Cancer Duwe G, Mercier D, Kauth V, Jost LM, Moench K, Rajashekar V, Junker M, Neumann CCM, Dengel A, Haferkamp A, Höfner T. PMID: 42235465 [PubMed - as supplied by publisher]
	Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review. Eur J Cancer Ahrens M, Haanen J, Albiges L, Goupil MG, Boleti E, Gravis G, Fléchon A, Grimm MO, Bedke J, Barthélémy P, Castellano D, Mellado B, Ivanyi P, Rottey S, Flörcken A, Suárez C, Maroto JP, Grünwald V, Oosting S, Kopecky J, Zschäbitz S, Boegemann M, Buchler T, Niegisch G, Goebell PJ, Waddell T, Joly F, Priou F, Retz M, Siemer S, Zimmermann U, Deckbar D, Burkholder I, Hartmann A, Bergmann L, Interdisciplinary Renal Cell Carcinoma Working Group of the DKG (IAGN). PMID: 42235464 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 473247

Seite 1 von 23663

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung